Bringing The Private Sector Voice to the Global Fund
We bring the unified voice of a diverse private sector actors to participate in the governance of the leading funding agency in global health. By leveraging private sector perspectives, capabilities and expertise, we help the Fund expand access to prevention, care and treatment for people impacted by HIV/AIDS, TB and malaria around the world.
We are part of a worldwide movement to combat the deadliest infectious diseases.
-
48%
In 2021, 48% of children infected with HIV globally were not getting the life-saving treatment they needed.
-
1.5 million+
In 2020, over 1.5 million people died of TB, including people living with HIV.
-
241 million
In 2020, there were an estimated 241 million cases of malaria and 627,000 malarian deaths worldwide.
Achieving the greatest impact requires global public-private cooperation.
The Global Fund Private Sector Constituency (PSC) is a group of multi-sectoral private sector entities committed to channeling private sector involvement in the Global Fund’s governance, programs and activities. The PSC has a demonstrated history of achieving extraordinary results, helping the Global Fund save 44 million lives since 2002 and committing billions of dollars to reshape the trajectory of AIDS, TB and malaria.
The Global Fund’s Board are comprised of 20 seats from countries, foundations and implementing partners. From its beginning, the Global Fund’s Board has maintained a seat for the private sector and the PSC is the organization that helps inform and shape the perspective of this board seat. The PSC also provides technical know-how, advocacy support, and ad-hoc contributions, all in support of the Global Fund’s overall mission and strategy.
The Global Fund
Since its inception in 2002, the Global Fund has saved more than 44 million lives and reduced the combined death rate from AIDS, TB and malaria by more than half in the countries it supports. The Global Fund has to date attracted and invested more than US$55 billion, keeping a high political focus on the three diseases and galvanizing partnerships and collaboration with civil society, businesses, and international organizations.
Our Latest
